Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in <i>Enterobacteriaceae</i>
Despite being members of gut microbiota, <i>Enterobacteriaceae</i> are associated with many severe infections such as bloodstream infections. The β-lactam drugs have been the cornerstone of antibiotic therapy for such infections. However, the overuse of these antibiotics has contributed...
Main Authors: | Giulia De Angelis, Paola Del Giacomo, Brunella Posteraro, Maurizio Sanguinetti, Mario Tumbarello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/5090 |
Similar Items
-
β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014-05-01) -
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
by: Annelien Everaert, et al.
Published: (2016-11-01) -
ß-Lactam-ß-lactamase Inhibitor Combination against ESBL-Producing Enterobacteriaceae
by: A Hashemi
Published: (2016-05-01) -
Could β-Lactam Antibiotics Block Humoral Immunity?
by: Cléa Melenotte, et al.
Published: (2021-09-01) -
Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
by: Elizabeth Story-Roller, et al.
Published: (2018-09-01)